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The present study was carried out to determine the in vitro 
hepatoprotective activity of ethanolic extract from Eichhornia 
crassipes (EEEC) flowers using the CCl4-challenged BRL3A cell 
model. Hepatoprotective activity of EEEC (at concentrations of 50, 
100 and 200 μg/mL) and standard drug silymarin (200 μg/mL) was 
evaluated against CCl4 induced toxicity using BRL3A cell line by 
measuring the cell viability, aspartate aminotransferase (AST), 
alanine aminotransaminase (ALT), lactate dehydrogenase (LDH) 
leakage, lipid peroxidation (LPO) and glutathione level (GSH). 
Treatment with CCl4 produced a significant decrease in cell 
viability. In addition, hepatotoxicity was revealed by increased 
hepatic marker enzymes like AST, ALT and LDH paralleled with 
elevated lipid peroxidation and decline in GSH levels. The toxicity 
induced by CCl4 in the BRL3A cells was significantly recovered by 
treatment with EEEC. The tested doses (100 and 200 μg/mL) 
significantly (P <0.01) reduced the CCl4 induced elevation of AST, 
ALT and LDH and also restored the altered biochemical 
parameters. These findings provide a basis for confirming the 
traditional uses of E. crassipes in treating liver ailments. 
Keywords: BRL3A cell line, CCl4, Eichhornia crassipes, 
Hepatoprotective. 
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Introduction 
Liver injury is a widespread medical ailment across 
the world and the most common causes of injury are viral 
infection, metabolic disorders, chemicals, medications, 
and/or alcohol abuse
1,2
. The hepatocyte death can 





tremendous progress in hepatology research, no 
significant and safe hepatoprotective drugs are available 
in the modern system of medicine
5
. Because of the 
undesirable side effects of synthetic drugs, there is a 
growing focus on the scientific evaluation of medicinal 
plants using systematic research methodology. 
Eichhornia crassipes (Mart.) Solms, also known as 
water hyacinth, is a free-floating aquatic plant that is 




The ‘beautiful blue devil’, 
water hyacinth is recognized by its lavender flowers 
and shining bright leaves
7
. In Bangladesh, roots and 
flowers are used in the treatment of hepatic disorders 










The hepatoprotective activity of
E. crassipes flowers is not yet known. Our previous
study revealed that ethanolic extract of E. crassipes
flowers has potent antioxidant activity when compared




Keeping the folkloric claims
and previous reports, an attempt was taken to evaluate
the hepatoprotective effect of ethanolic extract of
E. crassipes flowers.
Materials and Methods 
Plant material and extraction 
The flowers of E. crassipes were collected in the 
month of May, from the local pond near Budampadu 
village of Guntur district, Andhra Pradesh, India. The 
flowers are authenticated by the botanist Dr Madhava 
Chetty, Professor, Department of Botany, Sri 
Venkateswara University, Tirupathi, and a voucher 
specimen was deposited in the herbarium of the institution 
with reference number 2148 for future reference. The 
flowers were shade dried and were extracted in the 
Soxhlet extractor successively using solvents from non-
polar to polar (petroleum ether, ethyl acetate, and 
ethanol). All the extracts were vacuum dried to obtain 
petroleum ether extract (PEEC), ethyl acetate extract 
(EAEC), and ethanol extract (EEEC) respectively. 
Drugs and Chemicals 
Phosphate buffered saline (PBS), Fetal bovine serum 
(FBS), Dulbecco's modified eagle medium (DMEM), 
and trypsin were procured from Hi-Media Labs Pvt. Ltd 
(Mumbai, India). 3-(4, 5-dimethylthiazol-2-yl)-5-
diphenyltetrazolium bromide (MTT) and Silymarin were 
procured from Sigma Aldrich (MO, USA). All other 
chemicals and solvents used were of analytical grade. 
Hepatoprotective activity using BRL3A cell line 
Cell culture 
In the present study BRL3A (Buffalo Rat liver cell 








activity of EEEC. BRL3A was obtained from National 
Centre for Cell Sciences (NCCS), Pune, India. It was 
cultured in DMEM (Dulbecco’s modified eagles 
medium), supplemented with 10% inactivated fetal 
bovine serum (FBS), 100 IU/mL of penicillin, 100 μg/mL 
of streptomycin and 5 μg/mL amphotericin in a 
humidified atmosphere of 5% CO2 at 37 ºC until 
confluent. Later the cells were dissociated using TPVG 
solution (0.2% trypsin, 0.02% EDTA, 0.05% glucose in 
PBS). Stock cultures were grown in 25 cm
2
 culture flasks 
and the study was carried out in 96 microtitre plates. 
 
In vitro cytotoxicity assay 
MTT assay was carried out for EEEC to assess its 
nontoxic doses. After 24 hours of incubation, the 
hepatocytes were exposed to the fresh medium 
containing 100 μL of toxicant (medium containing 1% 
(v/v) CCl4) along with/without various concentrations 
of ethanolic extract (62.5-1000 μg/mL) or the medium 
alone (as normal) and the plates were incubated at  
37 °C in a humidified incubator with 5% CO2 for  
72 hours. After appropriate incubation, test samples in 
the wells were discarded and 50 μL of MTT in PBS 
was added to each well and then further incubated at 
the same growth parameters for 3 h. The supernatant 
was removed and 100 μL MTT solubilization solution 
was added to each well and the absorbance was read 
with a microplate reader at 540 nm. The 50% cytotoxic 
concentration (CTC)50 is the concentration of test drug 
that needed to inhibit cell growth by 50% is generated 




% Growth Inhibition = 100 - (Mean OD of individual 
                    test group / Mean OD of the 
                    control group) × 100 
 
CCl4 induced toxicity in BRL3A cell lines 
The non-toxic or safe concentration of the extract 
was chosen to assess the antihepatotoxic property. 
The hepatoprotective activity of EEEC was evaluated 
using well maintained BRL3A cell lines. Cells were 
treated with 100 µL each of culture medium 
containing 0.25% (v/v) DMSO; 1% (v/v) CCl4; 1% 
(v/v) CCl4 + silymarin (200 µg/mL); 1% (v/v) CCl4 + 
EECT (50, 100, 200 µg/mL); all the incubations were 
continued for 24 hours. Then, media and cell lysates 
were collected and stored at -20 ºC until further 
analysis. The activities of AST, ALT, and LDH in the 
supernatant medium were measured by using 
diagnostic kits according to the manufacturer’s 
instructions. The level of MDA and GSH in the cell 
lysates was measured using standard procedures
12,13
. 
Protein estimation was estimated using the Bradford 
protein assay, using bovine serum albumin as a 
protein standard
14
. The viability (%) was calculated 
using the below formula: 
 
% cell viability = (Mean OD of individual test group/ 
               Mean OD of the control group) × 100 
 
Statistical analysis 
Results were expressed as mean±standard error mean 
and statistical significance was analyzed by one-way 
ANOVA followed by Dunnett’s test using GraphPad 
Instat statistical software. Values of P <0.05 were 
considered significant in all cases. 
 
Results and Discussion 
In recent years, in vitro assays such as cell-based 
models are gaining importance due to their low cost, 
quick and reliability. The liver cell lines such as 
BRL3A and HepG2 are routinely used for preliminary 
screening of hepatoprotective agents, as they retain 
many characteristics of normal liver cells
15
. CCl4 is a 
hepatotoxic haloalkane whose mechanism has been 
studied intensively over the past years. It is well 
known that CCl4 undergoes metabolic activation by a 
cytochrome P-450 dependent step to free radical 
products which can initiate lipid peroxidation
16
. 
In this study, the hepatoprotective effect of  
E. crassipes flowers was investigated using CCl4 
induced hepatotoxicity in the BRL3A cell lines. Before 
evaluating the hepatoprotective activity of various 
concentrations of EEEC, it is mandatory to demonstrate 
that they are non-toxic. MTT test was used as an 
indicator of cytotoxicity induced by EEEC in infected 
BRL3A cells and a non-toxic dose was determined. This 
colorimetric assay involves the conversion of MTT to a 
purple formazan derivative by mitochondrial succinate 
dehydrogenase, which is present only in viable cells
17
. 
The % cytotoxicity of EEEC was found to be dose-
dependent and increases with increased concentrations. 
The % inhibition of cell proliferation at 62.5, 125, 250, 
500, and 1000 μg/mL was found to be 11.40±0.5, 
18.36±0.3, 28.16±0.6, 41.70±1.1, 52.70±1.0 respectively, 
with an IC50 value of 887 μg/mL (Table 1). The 
Table 1 — Cytotoxic properties of ethanolic extract of  
Eichhornia crassipes flowers against BRL3A cell line 
Test concentration % Cytotoxicity CTC50 (μg/mL) 
62.5 μg/mL 11.40±0.52  
 
887 
125 μg/mL 18.36±0.38 
250 μg/mL 28.16±0.69 
500 μg/mL 41.70±1.11 
1000 μg/mL 52.70±1.09 
Values are expressed as mean±SEM (n=3) 




concentrations used to study the hepatoprotective 
activity are found to be non-toxic for the BRL3A cell 
line. 
Table 2 depicts the results of cell viability and 
leakage parameters such as AST, ALT and LDH, 
MDA and GSH levels in all experimental groups. A 
significant decrease in cell viability and GSH content 
was observed in the BRL3A cells exposed to CCl4 
when compared with the DMSO control group. 
Similarly, toxin treatment caused a significant rise in 
the levels of AST, ALT, LDH, and MDA in BRL3A 
cells. It was found that treatment with various 
concentrations (50, 100, and 200 μg/mL) of EEEC 
significantly (P <0.01) increased the cell viability 
when compared to toxicant treated cells. The 
maximum protection observed with the extract was 
65.74% (200 μg/mL concentration) whereas the 
standard drug Silymarin at 200 μg/mL exhibited 
84.21%. EEEC at 100 and 200 μg/mL significantly  
(P <0.01) prevented the CCl4 induced elevation of 
AST, ALT, LDH, and MDA levels. Similarly, EEEC 
at 100 and 200 μg/mL significantly protected the 
decline in GSH activity when compared to toxicant 
treated cells (P <0.01). The higher concentrations of 
EEEC (100 and 200 μg/mL) are found to be more 
effective when compared to 50 μg/mL. 
Cells exposed to the toxic agents lose cell viability, 
release liver enzymes into the culture medium, do not 
metabolize the tetrazolium salt, and exhibit significantly 
changed total antioxidant capacity (TAOxC) and levels 
of MDA, SOD, and GSH
18,19
. The hepatoprotective 
mechanism was ascertained by evaluating the relevant 
parameters like enzyme leakage, quantification of 
intracellular malondialdehyde and glutathione levels. 
The possible underlying mechanism for the 
hepatoprotective effect of EEEC is due to its ability to 
inhibit lipid peroxidation and maintenance of glutathione 
in a reduced state by virtue of its antioxidative powers. 
Conclusion 
In conclusion, the obtained experimental data 
strongly support the view that E. crassipes can be 
used as a promising hepatoprotective agent. Detailed 
in vivo hepatoprotective studies are in progress in our 
laboratory which may further strengthen the 
protective nature. This study provides the first 
scientific evidence about the hepatoprotective nature 
of E. crassipes flowers. 
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